Merck's Cholesterol Pill Win Is Already Drawing Fire

The Food and Drug Administration just approved Liptruzet, a new cholesterol-lowering pill that combines the generically available ingredient available in Pfizer's Lipitor with Merck's Zetia. Merck has been working to get the combination pill approved for several years -- and one critic is already saying it was a mistake to approve the combination drug.